Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...

The ongoing, randomised, open-label Phase III 3475A-D77 trial (NCT05722015) investigating SC Keytruda delivered every six weeks met its primary endpoint demonstrating non-inferior PK when administered ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

By then, AstraZeneca and cancer drug partner Daiichi Sankyo had already validated the blockbuster potential of HER2-directed ADCs with Enhertu. But Eisai identified BB-1701 as a potential best-in ...

The sponsor should acknowledge that the indication authorized under the NOC/c pathway for Enhertu under control number 285834 can be withdrawn or revised, pending the outcome of Study U306. The ...

You should rotate these injection sites on your skin each time you inject insulin. There are different ways to take insulin, including syringes, insulin pens, insulin pumps, and jet injectors.

Paul George's first season with the Philadelphia 76ers is over. George, who hasn't played since March 4, received injections in his left adductor muscle and his left knee, the team announced Monday.

AstraZeneca has signed two deals worth $1.35 billion with Alteogen to develop subcutaneous versions of the British pharma’s cancer drugs despite a potential patent infringement risk. Monday, AZ ...

An appeals court on Friday lifted a block on President Donald Trump's executive orders ending federal support for diversity, equity and inclusion (DEI) programs. A panel of three judges ruled the ...

Hannah, whom Nadia calls her 'daughter', had been on Enhertu as part of a clinical trial that saw her also having to take a more toxic drug as part of its conditions. The mum-of-one's tumours had ...

Currently, five selective CDK4/6 inhibitors—ENHERTU, DATROWAY, IBRANCE, KISQALI, and VERZENIO—are used in combination with endocrine therapy. In November 2023, the FDA approved TRUQAP ...